Lannett Accused of Colluding With its Peers to Fix Generic Drug Prices Investors of Lannett (NYSE: LCI) filed a securities class action complaint against the company’s officers and directors for

Health Insurance Innovations Accused of Hiding Rejection of a Major License Application Investors of Health Insurance Innovations (NasdaqGM: HIIQ) filed a securities class action complaint against the company’s officers and

Applied Optoelectronics Accused of Hiding Loss of Business from Major Customer According to a recently filed class action complaint, Applied Optoelectronics (AAOI) officials predicted that the company would deliver another

Tableau Software, Inc. Accused of Concealing Competitive Threats Purchasers of Tableau Software, Inc. (DATA) filed a securities class action complaint against the company’s officers and directors for alleged violations of the

Electronics for Imaging, Inc. Accused of Improperly Recognizing Revenue Purchasers of Electronics for Imaging, Inc. (EFII) have filed a securities class action complaint for alleged violations of the Securities Exchange Act

Citizens Accused of Engaging in Ponzi Stock Scheme A securities class action complaint has been filed against Citizens. The complaint is brought on behalf of all purchasers of Citizens securities

Tivity Accused of Downplaying Competitive Risks to its Business According to the class action complaint against Tivity Health, Inc. (TVTY), despite acknowledging the risk that health plan customers could offer services

Alkermes Accused of Engaging in Deceptive Marketing Campaign According to a class action complaint, Alkermes PLC, Inc. (ALKS) represented to investors that the company used “customary pharmaceutical company practices to

Novan, Inc. (NOVN) Accused of Lying About its Clinical Trials According to the complaint, Novan, Inc. officials represented that the company performed two identical Phase 3 clinical trials for SB204.